Delost, Michael D., Smith, David T., Anderson, Benton J., and Njardarson, Jon T. From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles. Retrieved from https://par.nsf.gov/biblio/10284916. Journal of Medicinal Chemistry 61.24 Web. doi:10.1021/acs.jmedchem.8b00876.

Delost, Michael D., Smith, David T., Anderson, Benton J., & Njardarson, Jon T. From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles. Journal of Medicinal Chemistry, 61 (24). Retrieved from https://par.nsf.gov/biblio/10284916. https://doi.org/10.1021/acs.jmedchem.8b00876

Delost, Michael D., Smith, David T., Anderson, Benton J., and Njardarson, Jon T. "From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles". Journal of Medicinal Chemistry 61 (24). Country unknown/Code not available. https://doi.org/10.1021/acs.jmedchem.8b00876. https://par.nsf.gov/biblio/10284916.

@article{osti_10284916,
place = {Country unknown/Code not available}, title = {From Oxiranes to Oligomers: Architectures of U.S. FDA Approved Pharmaceuticals Containing Oxygen Heterocycles}, url = {https://par.nsf.gov/biblio/10284916}, DOI = {10.1021/acs.jmedchem.8b00876}, abstractNote = {}, journal = {Journal of Medicinal Chemistry}, volume = {61}, number = {24}, author = {Delost, Michael D. and Smith, David T. and Anderson, Benton J. and Njardarson, Jon T.}, editor = {null} }